An interventional study of Prism Adaptation - 15-degree prism goggles and Prism Adaptation - 5-degree prism goggles in Spatial Neglect, sponsored by Nova Scotia Health Authority. Recruiting at 4 sites in Canada. Per ClinicalTrials.gov, last updated 2025-07-30.
Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Stroke by Nova Scotia Health Authority — 5 open to participants now, 5 under way, none of them phase 3. Stroke · Nova Scotia Health Authority.
Among the 14 studies in Stroke by Nova Scotia Health Authority, this one has the largest planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2023, is one of 10 with no phase, and was the 10th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →5 of the 14 studies in Stroke by Nova Scotia Health Authority are open now, in 1 country. Recruiting first, the newest first:
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Nova Scotia Health Authority · Sites in Canada
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2023.
This study's planned enrollment of 80 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 14 across the 11 interventional studies, 62 across the 3 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Nova Scotia Health Authority is the lead sponsor of 264 studies on the registry; 77 are open to participants now.
4 of the studies in Stroke by Nova Scotia Health Authority that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05595668Nova Scotia Health AuthorityEngaging Mobile Prism Adaptation Treatment at Home | 2026-11 |
| NCT06864741Nova Scotia Health AuthorityVirtual Reality Rehabilitation for Stroke Patients in the Hospital and at Home. | 2027-06 |
| NCT06495450Nova Scotia Health AuthorityUsing Omnidirectional Virtual Reality and Treadmill Training for Chronic Stroke | 2027-08-06 |
| NCT07143162Nova Scotia Health AuthorityYOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke | 2027-10-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 14 studies in Stroke by Nova Scotia Health Authority, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Spatial neglect is a common disorder after stroke which leads to problems with noticing or responding to information from the left side of the body or space. This condition has been linked to reduced independence in a wide range of daily life activities including eating, dressing, and mobility. Despite its high prevalence in stroke patients, there is currently no standard of care for spatial neglect. Prism adaptation (PA) is a promising treatment, however, there are limitations to using PA in standard clinical care as it requires daily exposure for at least two weeks, yet access to equipment and supervision is limited. To solve this problem, the investigators have developed a new game-like PA treatment (Peg-the-Mole, PTM) that can be used at home without the need for daily in person therapist set-up and supervision. In this study the investigators aim to evaluate the feasibility and effectiveness of the gamified and portable PA procedure in an inpatient and home setting, with the hypothesis that the PA procedure will improve patient's neglect symptoms.
Spatial neglect is a common debilitating cognitive syndrome after stroke which is characterized by an inability to pay attention or respond to the left side of space. Thus, individuals who face this condition often experience difficulties with mobility, reading, and self-care activities such as eating, dressing, and grooming Individuals who face this condition often experience difficulties with mobility, reading, and self-care activities such as eating, dressing, and grooming which lead to increased assistance needed from a caretaker. Although this syndrome has been linked to poor rehabilitation outcomes and reduced independence in everyday life, there is currently an unmet need for an effective and feasible intervention for the treatment of spatial neglect. The investigators have developed and validated a novel, simple, and gamified computerized prism adaptation (PA) procedure for the treatment of spatial neglect. The goal of the present study is to extend this treatment to iPad administration and to test whether the protocol is feasible and effective in a typical inpatient stroke health care setting and in the home setting. Thus, the purpose of this project is to conduct a randomized, controlled, multi-site clinical trial, comparing the PA method to a placebo control intervention for the treatment of spatial neglect. The investigators will measure short- and longer-term effectiveness in terms of impairment (i.e., does PA improve neglect symptoms over time), impact on activities of daily living (i.e., foes PA improve independence in daily activities). Feasibility will be measured by overall treatment compliance and patient feedback on usability. This novel PA procedure has the potential to improve patient recovery and quality of life after stroke due to its gamified and portable features that promote treatment accessibility and adherence. The results will help determine if the treatment can be used successfully in inpatient and outpatient settings and who is likely to benefit.
A longitudinal, double-blind, randomized controlled design will be used in the present study. Patients will be randomly assigned (with stratification related to neglect severity) to PA with the use of 15-degree rightward deviating goggles (experimental condition) or PA with the use of 5-degree deviating goggles (placebo control condition). Participants will complete 10, 15-minute training sessions over approximately two weeks. These intervention sessions will involve using a novel and game-like iPad-administered PA procedure called Peg-the-Mole (PTM). Participants will complete the intervention sessions in an inpatient setting or in their homes, depending on their predicted length of hospital stay. A hybrid model will be adopted if a patient is discharged before the intervention is complete. Outcome measures will be collected immediately before, immediately after, and one-month post-treatment and compared between conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other existing neurological disorders (e.g., dementia, multiple sclerosis, epilepsy).
Prism Goggles with 15-degree rightward deviating prism lenses will be used to implement prism adaptation treatment, in addition to standard care.
Behavioral: Prism Adaptation - 15-degree prism goggles
Prism goggles with 5-degree rightward deviating prism lenses will be used to maintain the double-blind methodology.
Other: Prism Adaptation - 5-degree prism goggles
Patients in the experimental condition will wear prism goggles while completing an iPad-administered aiming task. The prisms will shift the patients' vision 15 degrees rightward, causing a recalibration of visuo-motor information. Prism adaptation will be carried out for ten sessions for 15 minutes a day, over the span of two weeks.
5-degree goggles are worn instead of the 15-degree prism goggles, while completing the same tasks as those assigned to the 15-degree condition.
Also known as: Control condition
Test of neglect severity 1
Change in Behavioural Inattention Test - All conventional subtests (BIT-C)
Time frame: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention
Test of neglect severity 2
Change in after-effects measured by a modified proprioceptive-and-visual straight-ahead outcome task without the use of an occlusion board
Time frame: measured immediately before and immediately after each intervention session
Test of neglect severity 3
Change in Behavioural Inattention Test - Select behavioural subtests (BIT-B): Article Reading, Menu Reading, and Picture Scanning
Time frame: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention
Test of neglect impact on daily activities
Change in an Eschenbeck Standardized Activities of Daily Living task: Filling out a Form
Time frame: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention
Scale of neglect impact on daily activities
Change in Halifax Neglect Impact Scale
Time frame: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention
Measure of feasibility Measure of feasibility
Treatment compliance with the intervention schedule daily
Time frame: logged immediately following each intervention session through training logs
Measure of feasibility 2
Patient feedback exit questionnaire
Time frame: collected immediately after the intervention
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Nov 2026, 38 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 38 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nova Scotia Health Authority →